Cite
Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administration.
MLA
Labonia, M. C. I., et al. “Cardiac Delivery of Modified MRNA Using Lipid Nanoparticles: Cellular Targets and Biodistribution after Intramyocardial Administration.” Journal of Controlled Release, vol. 369, May 2024, pp. 734–45. EBSCOhost, https://doi.org/10.1016/j.jconrel.2024.04.018.
APA
Labonia, M. C. I., Estapé Senti, M., van der Kraak, P. H., Brans, M. A. D., Dokter, I., Streef, T. J., Smits, A. M., Deshantri, A. K., de Jager, S. C. A., Schiffelers, R. M., Sluijter, J. P. G., & Vader, P. (2024). Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administration. Journal of Controlled Release, 369, 734–745. https://doi.org/10.1016/j.jconrel.2024.04.018
Chicago
Labonia, M.C.I., M. Estapé Senti, P.H. van der Kraak, M.A.D. Brans, I. Dokter, T.J. Streef, A.M. Smits, et al. 2024. “Cardiac Delivery of Modified MRNA Using Lipid Nanoparticles: Cellular Targets and Biodistribution after Intramyocardial Administration.” Journal of Controlled Release 369 (May): 734–45. doi:10.1016/j.jconrel.2024.04.018.